Evidence map›Paper›PMID 19861511›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2009

Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial.

Veronika Fedirko, Roberd M Bostick, W Dana Flanders, Qi Long, Eduard Sidelnikov, Aasma Shaukat, Carrie R Daniel, Robin E Rutherford, Jill Joelle Woodard

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00208793 (Calcium, Vitamin D, and Colon Cancer Risk Biomarkers), which is not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00208793 phase2completednot on this map

Calcium, Vitamin D, and Colon Cancer Risk Biomarkers

TypeinterventionalSponsorEmory UniversityRan2005 to 2013Enrolled92ConditionsColorectal Adenomatous PolypsArmsCalcium and vitamin D3 combined, Placebo, Calcium, Vitamin D3
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 124 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2010
    Trial
  11. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2010
    Trial
  12. Article
  13. Review
  14. Article
  15. Article
  16. Colorectal Cancer Chemoprevention: A Dream Coming True?International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
  19. Vitamin DStem cell research & therapy · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Veronika FedirkoDepartment of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Roberd M Bostick
W Dana Flanders
Qi Long
Eduard Sidelnikov
Aasma Shaukat
Carrie R Daniel
Robin E Rutherford
Jill Joelle Woodard
Division of Cancer Epidemiology and GeneticsEmory University · USNational Cancer Institute · USUniversity of Minnesota · US

Funding

Calcium, Vitamin D, and Colon Cancer Risk BiomarkersR01CA104637 · NCI · EMORY UNIVERSITY · PI BOSTICK, ROBERD MANER · 2004 to 2005
$565k
NCI NIH HHS R01 CA104637
6 · The paper itself

Abstract

To investigate the potential efficacy of calcium and vitamin D in reducing risk for colorectal neoplasms and to develop "treatable" phenotypic biomarkers of risk for colorectal neoplasms, we conducted a pilot, randomized, double-blind, placebo-controlled, 2 x 2 factorial clinical trial to test the effects of these agents on cell cycle markers in the normal colorectal mucosa. Ninety-two men and women with at least one pathology-confirmed colorectal adenoma were treated with 2 g/day calcium and/or 800 IU/day vitamin D(3) versus placebo over 6 months. Overall expression and distributions of p21(waf1/cip1) (marker of differentiation), MIB-1 (marker of short-term proliferation), and hTERT (marker of long-term proliferation) in colorectal crypts in the normal-appearing rectal mucosa were detected by automated immunohistochemistry and quantified by image analysis. In the calcium, vitamin D, and calcium plus vitamin D groups relative to the placebo, p21 expression increased by 201% (P = 0.03), 242% (P = 0.005), and 25% (P = 0.47), respectively, along the full lengths of colorectal crypts after 6 months of treatment. There were no statistically significant changes in the expression of either MIB-1 or hTERT in the crypts overall; however, the proportion of hTERT, but not MIB-1, expression that extended into the upper 40% of the crypts was reduced by 15% (P = 0.02) in the vitamin D plus calcium group relative to the placebo. These results indicate that calcium and vitamin D promote colorectal epithelial cell differentiation and may "normalize" the colorectal crypt proliferative zone in sporadic adenoma patients, and support further investigation of calcium and vitamin D as chemopreventive agents against colorectal neoplasms.

Indexed as

AdultAgedCalciumCell DifferentiationCell ProliferationCholecalciferolColonColorectal NeoplasmsCyclin-Dependent Kinase Inhibitor p21Double-Blind MethodDrug CombinationsFemaleHumansIntestinal MucosaMaleMiddle AgedCalciumCDKN1A protein, humanCholecalciferolCyclin-Dependent Kinase Inhibitor p21Drug CombinationsMIB1 ligase, humanPlacebosTelomeraseTERT protein, humanUbiquitin-Protein Ligases

Identifiers

PMID19861511
PMCPMC2784000
OpenAlexW2111083260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.